Psychedelic medicine biotech company MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ) reported Monday the results of a study on MDM...

Jason Raznick, the founder and CEO of Benzinga interviewed Kevin O’Leary on the “Raz Report” last week.

Jason Raznick, the founder and C

These days, the psychedelics finds itself in the midst of a public debate around the moral implications of patents and intellec...

Inside of a Legal Psilocybin Wellness Retreat At Benzinga, we do what we say, and we say what we do. This hands-on mentality a...

Mind Cure Closes $18M Raise Mind Cure Health Inc. (CSE:MCUR) recently announced the closing of a CA$23 Million ($18.1 million)...

On January 27, the Horizons Psychedelic Stock Index ETF (NEO:PSYK) became the first exchange traded fund to focus solely on the...

MindMed (NEO: MMED) (OTCQB:MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company announced a new partnership with Sw...

First Psychedelics ETF Debuts On NEO Exchange Psychedelics’ first exchange traded fund went public last Wednesday.

The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK.’ PSYK is the first ex...

In 2020, psychedelics took the world by storm. Over two dozen companies in the sector became publicly listed.